1. Johns Hopkins University Coronavirus Resource Center. Daily update.
2. WHO. World Health statistics 2019. Monitoring health for the sustainable development
a. goals.
3. Li B, Yang J, Zhao F et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020.
4. Liang W, Guan W, Chen R et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21:335-337.
5. Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol 2020;21:e180.
6. Kuderer N, Choueiri T, Shah D, et al. Clinical impact of COVID-19 in patients with cancer (CCC19): a cohort study. Lancet, June 20 2020; 395 (102410): 1907-1918 https://doi.org/10.1016/S0140-6736(20)31187-9
7. Ivanova L TD, Stoykova Z, Kostadinova T. Viral Diseases in Transplant and Immunocompromised Patients. In: K M, editor Immunopathology and Immunomodulation: InTechOpen, 2015.
8. Tuech JJ, Gangloff A, Di Fiore F, et al. Strategy f or the practice of digestive and oncological surgery during the COVID 19 epidemic. Jvissurg 2020.04.005
9. COVID Surg Collaborative. Gobal guidance for surgical care during the COVID 19 pandemic, BJS 2020.10.1002/bjs11646
10. Skulstad H, Cosyns B, Popescu B, et al. COVID-19 pandemic and cardiac imaging: EACVI recommendations in precautions, indications, prioritization, and protections for patients and healthcare personnel. Eur Heart J-CV Imag 2020; 21(6) 592-598.
11. Driggin E, Madhavan N, Bikdeli V et al. Cardiovascular considerations for patients, healthcare workers, and health systems during the COVID-19 pandemic. J Amer Coll Card 2020; 75(18) 2352-2371.
12. Word Health Organization: Rational use of personal protective equipment (PPE) for Coronavirus disease (COVID-19). Interim guidance 19 March 2020
13. Infection prevention and control of epidemic-and pandemic-prone acute respiratory infections in health care. Geneva: World Health Organization; 2014 (accessed 27 February 2020).
14. Ranney M, Griffeth V, Jha A. Critical supply shortages-The need for ventilators and personal protective equipment during the COVID 19 pandemic. N Engl J Med 2020;3 82:e41
15. Iacobucci G. COVID 19. Doctors still at considerable risk from lack of PPE, BMA warns. BMJ 2020; 368:m1316
16. Livingston E, Desai A, Berkwits M. Sourcing personal protective equipment during the COVID-19 pandemic. JAMA 2020; 323(19):1912-1914.
17. Cohen J, Kupferschmidt K. Countries test tactics in “war” against COVID-19. Science 2020. 367.6484. 1287-1288
18. Fudulu DP, Angelini GD. The COVID-19 crisis: reflections on cardiothoracic surgery training. J Card Surg. 2020;35(8):1765-6.
19. Melvin SC, Wiggins C, Burse N, Thompson E, Monger M. The Role of Public Health in COVID-19 Emergency Response Efforts From a Rural Health Perspective. Prev Chronic Dis. 2020;17:E70.
20. Schneider E. Failing the test-The tragic data gap undermining the US pandemic response. N Engl J Med. May 15 2020. DOI: 10.1056/NEJMp2014836
21. Dhama K, Sharun K, Tiwari R et al. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapies and treatments. Human vaccines and immunotherapies. DOI: 10.1080/21645515.2020.1735227
22. Sultana, Abida, et al. “Burnout Among Healthcare Providers During COVID-19 Pandemic: Challenges and Evidence-based Interventions.” SocArXiv, 14 Apr. 2020. Web.
23. Dewey C, Hingle S, Goelz E, et al. Supporting clinicians during the COVID-19 pandemic.Ann Int Med March 2020. https://doi.org/10.7326/M20-1033
24. https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/specialty-guide-cardiolgy-coronavirus-v1-20-march.pdf
25. Wysocki PJ, Kwinta Ł, Potocki P et al. Systemic treatment of patients with solid tumors during the COVID-19 (SARS-CoV-2) pandemic- recommendations of the Polish Society of Clinical Oncology. Oncol Clin Pract 2020;16(2):41-51. DOI: 10.5603/OCP.2020.0012.
26. Ebinger J, Shah PK. The. Declining admissions for acute cardiovascular illness: the COVID 19 paradox. J Amer Coll Cardiol JACC 2020.05.039
27. Bhatt A, Moscone A, Mc Elrath E, et al. Declines in hospitalizations for acute cardiovascular conditions during the COVID 19 pandemic: a multicenter tertiary care experience. J Am Coll Cardiol. 2020 May 22. Epublished DOI:10.1016/j.jacc.2020.05.038
28. Mahmud E, Dauerman H, et al. Mangement of acute myocardial infarction during the COVID 19 pandemic. J Am Coll Cardiol. 2020 Apr 30. Epublished DOI:10.1016/j.jacc.2020.04.039
29. Ueda M, Martins R, et al. Managing cancer care during the COVID 19 pandemic. Agility and collaboration toward a common goal. JNCCN, 19 Mar 2020, :1-4
DOI: 10.6004/jnccn.2020.7560
30. Calabro L, Peters S, et al. Challenges in lung cancer therapy during the COVID 19 pandemic. Lancet Respir Med. 2020 Apr 9 doi: 10.1016/S2213-2600(20)30170-3 [Epub ahead of print].
31. Maringe G, Spicer J et al. The Impact on Covid 19 pandemic on cancer deaths due to delay in diagnosis in England, UK. Lancet Oncol 2020;21:1023-34
32. Van de Haar, J., Hoes, L.R., Coles, C.E. et al. Caring for patients with cancer in the COVID-19 era. Nat Med 26, 665–671 (2020).
https://doi.org/10.1038/s41591-020-0874-8.
33. Chikwee J, Gaudino M, Hameed I et al, Committee recommendations for resuming cardiac surgery activity in the SARS-COV-2 era: guidance from an international cardiac surgery consortium. Ann Thorac Surg May 15 2020. https://doi.org/10.1016/j.athoracsur.2020.05.004
34. Rao P, Diamond J,Korjian S, et al. The impact of the COVID-19 pandemic in cardiovascular fellows in training: a national survey. J Am Coll Cardiol. 2020 Jun 16. Unpublished DOI:10.1016/j.jacc.2020.06.027
35. Fix O.K, Serper M, Telemedicine and Telehepatology during the COVID 19 Pandemic. Clin Liver Dis May 2020; 15(5): 187-190.
36. Smith A, Thomas E, Snoswell C et al.Telehealth for global emergencies. Implications for COVID 19. Sage Journals. March 20, 2020. doi.org/10.1177/1357633X20916567
37. Ohannessian R, Duong TA, Odone A. Global telemedicine implementation and integration within health systmes to fight the COVID 19 pandemic: a call to action. JMIR 6 (2), 2020. April June
38. Eberly L, Khatana S, Nathan A et al. Telemedicine outpatient cardiovascular care during the COVID 19 pandemic: Bridging or opening the digital divide? Circulation. June 8 2020. https://doi.org/10.1161/CIRCULATIONAHA.120.048185
39. Grein J,Ohmagari N, Shin D et al. Compassionate use of remdesivir for patients with COVID 19. NEJM April 10 2020. DOI: 10.1056/NEJMoa2007016
40. Wang Y, Zhang D, Du H, et al. Remdesivir in adults with severe COVID 19: a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet 395 (10236): 1569-1578
41. Beigel J, Tomashek KM, Dodd el et al, for the ACTT-1 Study Group Members. Remdesivir for the treatment of COVID 19. NEJM May 22 DOI: 10.1056/NEJMoa2007764
42. Zhang C, Wu Z, Li J-W, et al. Cytokine release syndrome in COVID-19: interleukin 6 receptor antagonist tocilizumab may be the key to reduce mortality. Int Jour Antimic Ag 2020; 55 (5) https://doi.org/10.1016/j.ijantimicag.2020.105954
43. Alzghari S, Acuna V. Supportive treatment with tocilizumab for COVID-19: a systematic review. J Clin Virol 2020; 127:104380. 10.1016/j.jcv.2020.104380
44. Goldman JD, Lyle D, Hui D, et al. Remdesivir for 5 or 10 days in patients with severe COVID 19. NEJM May 27, 2020 DOI: 10.1056/NEJMoa2015301.
45. Dolin R, Hirsch M. Remdesivir, an important first step. N Engl J Med. May 27 2020. DOI: 10.1056/NEJMe2018715
46. Hopkins Tanne J, Hayasaki E, Zastrow M, et al: COVID 19. How doctors and healthcare systems are tackling coronavirus worldwide. BMJ 2020;368:m 1090.
47. Brzezinski A, Kecht V, Van Dijcke D, Wright A. Belief in science influences physical distancing in response to COVID 19 lockdown policies. Becker Friedman Institute for Economics. Univ of Chicago. April 2020.
48. Khosrawipour V, Lau H, et al. Failure in initial stage containment of global COVID-19 epicenters. J of Med Virol April 16 2020. https://doi.org/10.1002/jmv.25883
49. Anelli F, Leoni G, Monaco R et al. Italian doctors call for protecting healthcare workers and boosting community surveillance during covid-19 outbreak. BMJ 2020; 368:m1254 doi: https://doi.org/10.1136/bmj.m1254
50. Public Health, Medical Associations Call on Federal Authorities, State and Local Governments to Prioritize Safety in COVID-19 Policies. ACC, ASCO and 40 Professional medical societies joint statement. April 29 2020.
51. Mahmud E, Dauerman HL, Welt FGP, Messenger JC, Rao SV, Grines C, et al. Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). Catheter Cardiovasc Interv. 2020;96(2):336-45.
52. Marron JM, Joffe S, Jagsi R, Spence RA, Hlubocky FJ. Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID-19 Pandemic. J Clin Oncol. 2020;38(19):2201-5.
53. Shah PB, Welt FGP, Mahmud E, Phillips A, Kleiman NS, Young MN, et al. Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement. Catheter Cardiovasc Interv. 2020.